169 related articles for article (PubMed ID: 35193947)
1. Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus.
Zhu L; Singh M; Lele S; Sahakian L; Grossman J; Hahn B; McMahon M
Lupus Sci Med; 2022 Feb; 9(1):. PubMed ID: 35193947
[TBL] [Abstract][Full Text] [Related]
2. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
Eur J Prev Cardiol; 2021 Apr; 28(3):346-352. PubMed ID: 33891687
[TBL] [Abstract][Full Text] [Related]
3. Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE.
Panopoulos S; Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
Lupus Sci Med; 2023 Mar; 10(1):. PubMed ID: 36868585
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus.
Sivakumaran J; Harvey P; Omar A; Tayer-Shifman O; Urowitz MB; Gladman DD; Anderson N; Su J; Touma Z
Lupus Sci Med; 2021 May; 8(1):. PubMed ID: 34045359
[TBL] [Abstract][Full Text] [Related]
5. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
Eur J Prev Cardiol; 2020 Mar; ():2047487320906650. PubMed ID: 32122200
[TBL] [Abstract][Full Text] [Related]
6. Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head.
Barinotti A; Radin M; Cecchi I; Foddai SG; Arbrile M; Rubini E; Menegatti E; Roccatello D; Sciascia S
Int J Cardiol; 2022 Sep; 363():185-189. PubMed ID: 35714714
[TBL] [Abstract][Full Text] [Related]
7. QRISK3 relation to carotid plaque is higer than that of score in patients with systemic lupus erythematosus.
Quevedo-Abeledo JC; Caceres L; Palazuelos C; Llorca J; González-Gay MÁ; Ferraz-Amaro I
Rheumatology (Oxford); 2022 Apr; 61(4):1408-1416. PubMed ID: 34240117
[TBL] [Abstract][Full Text] [Related]
8. Framingham, ACC/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation?
Di Battista M; Tani C; Elefante E; Chimera D; Carli L; Ferro F; Stagnaro C; Mosca M
Clin Exp Rheumatol; 2020; 38(4):602-608. PubMed ID: 31694741
[TBL] [Abstract][Full Text] [Related]
9. Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus.
Choi MY; Guan H; Yoshida K; Paudel M; Kargere BA; Li D; Ellrodt J; Stevens E; Cai T; Weber BN; Everett BM; Costenbader KH
Semin Arthritis Rheum; 2024 Aug; 67():152468. PubMed ID: 38788567
[TBL] [Abstract][Full Text] [Related]
10. QRISK3-based analysis of cardiovascular risk factors in patients with long-term but well-controlled systemic lupus erythematosus.
Wang SL; Li W; Li TF; Liang X; Yan YL; Liu SY
Am J Transl Res; 2022; 14(5):3247-3260. PubMed ID: 35702101
[TBL] [Abstract][Full Text] [Related]
11. Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus.
Mu X; Wu A; Hu H; Zhou H; Yang M
Front Endocrinol (Lausanne); 2022; 13():1077632. PubMed ID: 36518244
[TBL] [Abstract][Full Text] [Related]
12. The Expanded Risk Score in Rheumatoid Arthritis (ERS-RA): performance of a disease-specific calculator in comparison with the traditional prediction scores in the assessment of the 10-year risk of cardiovascular disease in patients with rheumatoid arthrit.
Salaffi F; Carotti M; Di Carlo M; Tardella M; Lato V; Becciolini A; Favalli EG; Giovagnoni A
Swiss Med Wkly; 2018 Aug; 148():w14656. PubMed ID: 30141517
[TBL] [Abstract][Full Text] [Related]
13. QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus.
Edwards N; Langford-Smith AWW; Parker BJ; Bruce IN; Reynolds JA; Alexander MY; McCarthy EM; Wilkinson FL
Lupus Sci Med; 2018; 5(1):e000272. PubMed ID: 30167314
[TBL] [Abstract][Full Text] [Related]
14. Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus.
Urowitz MB; Ibañez D; Su J; Gladman DD
J Rheumatol; 2016 May; 43(5):875-9. PubMed ID: 26879352
[TBL] [Abstract][Full Text] [Related]
15. State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus.
Zhao M; Feng R; Werth VP; Williams KJ
Lupus Sci Med; 2023 Aug; 10(2):. PubMed ID: 37604650
[TBL] [Abstract][Full Text] [Related]
16. Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus.
Vázquez-Del Mercado M; Perez-Vazquez FJ; Gomez-Bañuelos E; Chavarria-Avila E; Llamas-García A; Arrona-Rios KI; Diaz-Rubio GI; Durán-Barragán S; Navarro-Hernández RE; Jordán-Estrada BP; Prado-Bachega N; Gonzalez-Beltran MAA; Ramos-Becerra C; Grover-Paez F; Cardona-Müller D; Cardona-Muñoz EG
PLoS One; 2018; 13(12):e0207520. PubMed ID: 30517121
[TBL] [Abstract][Full Text] [Related]
17. Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study.
Corrales A; Vegas-Revenga N; Rueda-Gotor J; Portilla V; Atienza-Mateo B; Blanco R; Castañeda S; Ferraz-Amaro I; Llorca J; González-Gay MA
Semin Arthritis Rheum; 2020 Dec; 50(6):1333-1338. PubMed ID: 32416998
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
[No Abstract] [Full Text] [Related]
19. Atherogenic Index of Plasma in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A 10-Year Potential Predictor of Cardiovascular Disease.
Hammam N; Abdel-Wahab N; Gheita TA
Curr Rheumatol Rev; 2021; 17(1):122-130. PubMed ID: 33030132
[TBL] [Abstract][Full Text] [Related]
20. Performance evaluation of 10-year ultrasound image-based stroke/cardiovascular (CV) risk calculator by comparing against ten conventional CV risk calculators: A diabetic study.
Khanna NN; Jamthikar AD; Gupta D; Nicolaides A; Araki T; Saba L; Cuadrado-Godia E; Sharma A; Omerzu T; Suri HS; Gupta A; Mavrogeni S; Turk M; Laird JR; Protogerou A; Sfikakis PP; Kitas GD; Viswanathan V; Suri JS
Comput Biol Med; 2019 Feb; 105():125-143. PubMed ID: 30641308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
